These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3283584)

  • 1. Steroid-induced hypertension in patients with nephrotic syndrome.
    Klepikov PV; Kutyrina IM; Tareyeva IE
    Nephron; 1988; 48(4):286-90. PubMed ID: 3283584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulse therapy of patients with nephritis: effect on arterial pressure, electrolyte metabolism and the renin-aldosterone system].
    Klepikov PV; Kutyrina IM; Lukovnikova LP
    Ter Arkh; 1985; 57(6):81-3. PubMed ID: 3906991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling.
    Meltzer JI; Keim HJ; Laragh JH; Sealey JE; Jan KM; Chien S
    Ann Intern Med; 1979 Nov; 91(5):688-96. PubMed ID: 496101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium retention in nephrotic syndrome is due to an intrarenal defect: evidence from steroid-induced remission.
    Brown EA; Markandu N; Sagnella GA; Jones BE; MacGregor GA
    Nephron; 1985; 39(4):290-5. PubMed ID: 3982574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The sodium-renin profile and intravascular blood volume in the pathogenesis of steroid hypertension in patients with glomerulonephritis].
    Tareeva NE; Klepikov PV; Kutyrina IM
    Vestn Akad Med Nauk SSSR; 1985; (11):14-20. PubMed ID: 4090649
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyporeninemic hypoaldosteronism in patients with nephrotic syndrome.
    Usberti M; Gazzotti RM
    Am J Nephrol; 1998; 18(3):251-5. PubMed ID: 9627045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
    Plum J; Mirzaian Y; Grabensee B
    Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations on the sodium retention in nephrotic syndrome.
    Usberti M; Gazzotti RM; Poiesi C; D'Avanzo L; Ghielmi S
    Am J Nephrol; 1995; 15(1):38-47. PubMed ID: 7872363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of plasma volume expansion on renal salt handling in patients with the nephrotic syndrome.
    Koomans HA; Geers AB; vd Meiracker AH; Roos JC; Boer P; Dorhout Mees EJ
    Am J Nephrol; 1984; 4(4):227-34. PubMed ID: 6383042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma atrial natriuretic peptide and natriuretic response to water immersion in patients with nephrotic syndrome.
    Hwang SJ; Tsai JH; Lai YH; Chen JH
    Nephron; 1991; 58(3):330-8. PubMed ID: 1832746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelationships between sodium clearance, plasma aldosterone, plasma renin activity, renal hemodynamics and blood pressure in renal disease.
    Reubi FC; Weidmann P; Glück Z
    Klin Wochenschr; 1979 Dec; 57(23):1273-85. PubMed ID: 397972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of renin and aldosterone by small amounts of DOCA in normal man.
    Shade RE; Grim CE
    J Clin Endocrinol Metab; 1975 Apr; 40(4):652-8. PubMed ID: 1127075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma renin activity (PRA) and aldosterone (PA) in patients with chronic glomerulonephritis (GN) and hypertension.
    Bras H; Ochs HG; Armbruster H; Heintz R
    Clin Nephrol; 1976 Feb; 5(2):57-60. PubMed ID: 943254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of sodium restriction to abolish exaggerated natriuresis in poststreptococcal glomerulonephritis.
    Schacht RG; Steele JM; Lowenstein J; Baldwin DS
    Nephron; 1977; 18(6):333-41. PubMed ID: 876440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
    Pedraza-Chaverrí J; Cruz C; Ibarra-Rubio ME; Chávez MT; Calleja C; Tapia E; del Carmen Uribe M; Romero L; Peña JC
    Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of the renin-angiotensin system in the pathogenesis of nephrotic syndrome].
    Kutyrina IM; Klepikov PV; Tareeva IE
    Ter Arkh; 1988; 60(6):32-4. PubMed ID: 3061050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-angiotensin-aldosterone system in nephrotic syndrome.
    Hammond TG; Whitworth JA; Saines D; Thatcher R; Andrews J; Kincaid-Smith P
    Am J Kidney Dis; 1984 Jul; 4(1):18-23. PubMed ID: 6377881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of renin angiotensin aldosterone on minimal change nephrotic syndrome.
    Kumagai H; Onoyama K; Iseki K; Omae T
    Clin Nephrol; 1985 May; 23(5):229-35. PubMed ID: 4006331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of sodium retention in nephrotic syndrome: role of aldosterone and glomerular filtration].
    Reubi FC; Weidmann P
    J Urol Nephrol (Paris); 1978 Sep; 84(9):643-6. PubMed ID: 748584
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma volume in nephrotic patients showing chronic glomerulonephritis with normal kidney function.
    Onoyama K; Kumagai H; Fujishima M
    Nihon Jinzo Gakkai Shi; 1988 Mar; 30(3):259-64. PubMed ID: 3050207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.